| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) | 
|---|
| 08/08/2000 | US6100405 Benzothiazole-containing two-photon chromophores exhibiting strong frequency upconversion | 
| 08/08/2000 | US6100404 Erythromycin compounds | 
| 08/08/2000 | US6100282 Thiazole derivatives | 
| 08/08/2000 | US6100277 Retroviral protease inhibitor combinations | 
| 08/08/2000 | US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example | 
| 08/03/2000 | WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors | 
| 08/03/2000 | WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors | 
| 08/03/2000 | WO2000044717A2 Synthesis of oligoketides | 
| 08/03/2000 | WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS | 
| 08/03/2000 | WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant | 
| 08/03/2000 | WO2000006146A9 Substituted anilide compounds and methods | 
| 08/03/2000 | DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis | 
| 08/03/2000 | CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors | 
| 08/03/2000 | CA2361040A1 Synthesis of oligoketides | 
| 08/03/2000 | CA2360671A1 P53 inhibitors and therapeutic use of the same | 
| 08/03/2000 | CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors | 
| 08/02/2000 | EP1024134A1 Aminobutanoic acid derivatives | 
| 08/02/2000 | EP1023277A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy | 
| 08/02/2000 | EP1023057A1 Use of thiazolidinediones for the treatment of hyperglycaemia | 
| 08/02/2000 | EP1023056A1 Use of thiazolidinediones for the treatment of hyperglycaemia | 
| 08/02/2000 | CN1261883A Novel compounds | 
| 08/01/2000 | US6096782 Administering an alanine containing peptide to the alzhiemer's patient | 
| 08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding | 
| 08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents | 
| 08/01/2000 | US6096499 Mammalian DNA primase screen and activity modulating agents | 
| 08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists | 
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids | 
| 07/27/2000 | WO2000043535A2 Composition and device for detecting leukocytes in urine | 
| 07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | 
| 07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | 
| 07/27/2000 | WO2000043007A1 Troglitazone-containing medicinal compositions for inhibiting apoptosis | 
| 07/27/2000 | WO2000043006A1 Inhibitor for nerve cell death due to glutamic acid cytotoxicity | 
| 07/27/2000 | WO2000027832A3 Thiazole derivatives as ppar gamma ligands | 
| 07/27/2000 | WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands | 
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors | 
| 07/27/2000 | WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 | 
| 07/27/2000 | CA2359689A1 Composition and device for detecting leukocytes in urine | 
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | 
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 | 
| 07/26/2000 | EP1022274A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use | 
| 07/26/2000 | EP1022267A2 Process for the manufacture of diazonium compounds with a low sodium ions content | 
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders | 
| 07/26/2000 | EP1021409A1 Heterocyclic compounds as pesticides | 
| 07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS | 
| 07/26/2000 | CN1261357A Process for producing 2-hydroxybenzamide derivatives | 
| 07/26/2000 | CN1261345A Glyoxylic acid amides | 
| 07/26/2000 | CN1261276A Protease inhibitors | 
| 07/26/2000 | CN1054847C Process for production of fluoroalkanecarboxamide derivatives | 
| 07/26/2000 | CN1054846C Use of intermediates for production of aromatic aminoalcohol derivatives having anti-diabetic and anti-obesity properties | 
| 07/25/2000 | US6093823 By continuous racemate splitting via diastereomeric salt pairs with re-racemisation of the residual amino acid or amino acid derivative in the mother liquid with the aid of an optically active acid | 
| 07/25/2000 | US6093742 Inhibitors of p38 | 
| 07/25/2000 | US6093733 Muscarinic receptor agonists | 
| 07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases | 
| 07/25/2000 | CA2031463C Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them | 
| 07/20/2000 | WO2000042099A1 In situ preparation of a bis-(benzothiazolesulfen)amide in a polymeric matrix | 
| 07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists | 
| 07/20/2000 | WO2000042032A1 Substituted 2-imino thiazolines | 
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | 
| 07/20/2000 | WO2000042022A1 Benzoheterocycles and their use as mek inhibitors | 
| 07/20/2000 | WO2000042007A1 Alfa-sulfenimino acid derivatives | 
| 07/20/2000 | WO2000041999A1 Oxime derivatives and uses thereof | 
| 07/20/2000 | WO2000041997A1 Process for the preparation of optically active amino alcohols | 
| 07/20/2000 | WO2000003709A9 Novel dna-cleaving antitumor agents | 
| 07/20/2000 | DE10001644A1 New fluorinated azole compounds, used in liquid crystal mixtures or as pharmaceuticals or agrochemicals or their intermediates | 
| 07/20/2000 | CA2359780A1 In situ preparation of a bis-(benzothiazolesulfen)amide in a polymeric matrix | 
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | 
| 07/20/2000 | CA2296173A1 A process for the production of diazonium compounds with a low content of sodium ions | 
| 07/20/2000 | CA2296128A1 A process for the production of diazonium compounds with a low content of sodium ions | 
| 07/19/2000 | EP1020454A1 Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof | 
| 07/19/2000 | EP1020451A1 Novel anilide compounds and drugs containing the same | 
| 07/19/2000 | EP1020441A1 N-heterocyclic methylpropylamine derivatives, process for producing the same and germicides | 
| 07/19/2000 | EP1019389A2 Epothilone derivatives | 
| 07/19/2000 | EP1019386A1 Reverse hydroxamate derivatives as metalloprotease inhibitors | 
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS | 
| 07/19/2000 | EP1019358A1 Novel compounds, their use and preparation | 
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS | 
| 07/19/2000 | EP1019046A1 Protease inhibitors | 
| 07/19/2000 | EP0775696B1 Amino acid amide derivative, process for producing the same, agrohorticultural fungicide, and fungicidal method | 
| 07/19/2000 | EP0757987B1 Pyrazole-carboxylic acid derivatives as plant disease control agents | 
| 07/19/2000 | EP0674626B1 Selective aromatase inhibiting compounds | 
| 07/19/2000 | EP0514452B2 Use of insulin sensitizing agents to treat hypertension | 
| 07/19/2000 | CN1260783A 2-sulfamoylbenzoic acid derivatives | 
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same | 
| 07/18/2000 | US6090846 Administering s-ethyl-n-((4-trifluoromethyl)phenyl)isothiourea | 
| 07/18/2000 | US6090833 Polycyclic dihydrothiazoles, their preparation, and use as pharmaceuticals | 
| 07/18/2000 | US6090810 Side effect reduction | 
| 07/13/2000 | WO2000040560A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists | 
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors | 
| 07/13/2000 | WO2000040539A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | 
| 07/13/2000 | WO2000040210A2 Topical compositions comprising protected functional thiols | 
| 07/13/2000 | DE19900824A1 Substituierte 2-Imino-thiazoline Substituted 2-imino-thiazolines | 
| 07/13/2000 | CA2356053A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | 
| 07/12/2000 | EP1017693A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them | 
| 07/12/2000 | EP0613468B1 Substituted salicylic acids for the treatment of autoimmune diseases | 
| 07/12/2000 | CN1259936A Method for producing nitroguanidine derivatives | 
| 07/11/2000 | US6087508 Process for the preparation of benzothiazolone compounds | 
| 07/11/2000 | US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids | 
| 07/11/2000 | US6087367 Potent inducers of terminal differentiation and methods of use thereof | 
| 07/11/2000 | US6087355 A therapeutic bactericide composition for treating a methicillin-resistant, vancomycin-resistant, or ampicillin-resistant bacterial infection | 
| 07/06/2000 | WO2000039086A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities |